Chimére L Sweeney emphasizes the need for awareness, stating, "I want to help Black people tell their stories of long covid." The discussion highlights the importance of empathy and support for those affected, advocating for better healthcare access and understanding.
Danielle Beckham Neuroscientist at the @CNPRCresearch . MS in Biophysics, PhD in Biological Chemistry. With her latest entry to NeuroArt "Unwelcome guest: SARS-Cov-2" - If you like it, please vote!
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t
A study on long Covid patients revealed persistent immune activation and potential virus presence in various organs even years after infection. The research utilized imaging techniques to identify immune activation in the brain, spinal cord, lungs, and gut wall. The findings suggest a need for further investigation into treatments targeting leftover virus and immunomodulating therapies....
with further research existing treatments targeting the eradication/reduction of these type of autoantibodies for Long COVID could be used and biomarkers (blood tests to show the presence of Long COVID) could be developed to identify these autoantibodies in Long Haulers who have these types of neurological symptoms, particularly those with chronic pain.
A research paper has revealed that children and adolescents who have COVID-19 were at a higher risk of developing major kidney problems post COVID infection, even if they had no prior kidney disease...
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
Unite to Fight | We envision a world free of Long Covid & ME/CFS stigmatization, where every individual can thrive.
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years